Form 4: Teladoc Health Executive Kelly Bliss Reports Stock Transactions

Kelly Bliss, President, U.S. Group Health at Teladoc Health, reported the vesting of restricted stock units and subsequent sale of shares to cover tax obligations.

Summary

• On October 1, 2024, Kelly Bliss, President, U.S. Group Health at Teladoc Health, vested 2,631 restricted stock units, each representing a contingent right to receive one share of TDOC common stock.
• Following the vesting, 897 shares were sold on October 2, 2024, at a price of $8.677 per share to cover tax withholding obligations.
• After these transactions, Ms. Bliss directly owns 28,203 shares of Teladoc Health common stock.

Sentiment

Score: 5

Explanation: This is a routine transaction related to stock compensation and tax obligations, and doesn't necessarily indicate a positive or negative sentiment towards the company's future prospects.

Industry Context

Form 4 filings are a routine part of the stock market, providing transparency into the transactions of company insiders. These filings are closely watched by investors seeking insights into management's perspective on the company's stock.

Stakeholder Impact

• The sale of shares by an executive could have a minor impact on shareholder sentiment, but is likely insignificant given the context of tax obligations.

Key Dates